Literature DB >> 19171208

Diabetic macular edema: pathogenesis and treatment.

Neelakshi Bhagat1, Ruben A Grigorian, Arthur Tutela, Marco A Zarbin.   

Abstract

Diabetic macular edema is a major cause of visual impairment. The pathogenesis of macular edema appears to be multifactorial. Laser photocoagulation is the standard of care for macular edema. However, there are cases that are not responsive to laser therapy. Several therapeutic options have been proposed for the treatment of this condition. In this review we discuss several factors and mechanisms implicated in the etiology of macular edema (vasoactive factors, biochemical pathways, anatomical abnormalities). It seems that combined pharmacologic and surgical therapy may be the best approach for the management of macular edema in diabetic patients.

Entities:  

Mesh:

Year:  2009        PMID: 19171208     DOI: 10.1016/j.survophthal.2008.10.001

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  154 in total

1.  Efficacy of Ozurdex implant in recalcitrant diabetic macular edema--a single-center experience.

Authors:  Pooja Bansal; Vishali Gupta; Amod Gupta; Mangat Ram Dogra; Jagat Ram
Journal:  Int Ophthalmol       Date:  2015-08-02       Impact factor: 2.031

2.  In vivo adaptive optics microvascular imaging in diabetic patients without clinically severe diabetic retinopathy.

Authors:  Stephen A Burns; Ann E Elsner; Toco Y Chui; Dean A Vannasdale; Christopher A Clark; Thomas J Gast; Victor E Malinovsky; Anh-Danh T Phan
Journal:  Biomed Opt Express       Date:  2014-02-27       Impact factor: 3.732

3.  Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I/II clinical study.

Authors:  Catherine A Cukras; Philip Petrou; Emily Y Chew; Catherine B Meyerle; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-22       Impact factor: 4.799

4.  Three-dimensional structural and angiographic evaluation of foveal ischemia in diabetic retinopathy: method and validation.

Authors:  Bingjie Wang; Acner Camino; Shaohua Pi; Yukun Guo; Jie Wang; David Huang; Thomas S Hwang; Yali Jia
Journal:  Biomed Opt Express       Date:  2019-06-24       Impact factor: 3.732

5.  Novel Approaches for Retinal Drug and Gene Delivery.

Authors:  Stephen J Kim
Journal:  Transl Vis Sci Technol       Date:  2014-10-03       Impact factor: 3.283

6.  Current treatments in diabetic macular oedema: systematic review and meta-analysis.

Authors:  John Alexander Ford; Noemi Lois; Pamela Royle; Christine Clar; Deepson Shyangdan; Norman Waugh
Journal:  BMJ Open       Date:  2013-03-01       Impact factor: 2.692

7.  Targeting the pathophysiology of diabetic macular edema.

Authors:  Pedro Romero-Aroca
Journal:  Diabetes Care       Date:  2010-11       Impact factor: 17.152

8.  Optical coherence tomography for age-related macular degeneration and diabetic macular edema: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-09-01

9.  Intravitreal dexamethasone implants for diabetic macular edema.

Authors:  Alicia Pareja-Ríos; Paloma Ruiz-de la Fuente-Rodríguez; Sergio Bonaque-González; Maribel López-Gálvez; Virginia Lozano-López; Pedro Romero-Aroca
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

10.  Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness.

Authors:  Banu Turgut Ozturk; Banu Bozkurt; Hurkan Kerimoglu; Mehmet Okka; Umit Kamis; Kemal Gunduz
Journal:  Mol Vis       Date:  2009-09-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.